跳至主要内容
临床试验/NCT03344302
NCT03344302已完成4 期

Oxytocin Administration During Cesarean Section Before Versus After Fetal Delivery Randomized Clinical Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2016年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
200
试验地点
1
主要终点
rate of blood loss

研究概览

简要总结

Cesarean delivery is defined as fetal birth through incisions in the abdominal wall and the uterine wall. This definition does not include removal of the fetus from the abdominal cavity in the case of uterine rupture or in the case of an abdominal pregnancy The guidelines of the Royal College of Obstetricians and Gynaecologists on caesarean section recommend a slow intravenous bolus dose of 5 IU of oxytocin after delivery of the infant. Intravenous oxytocin has a short half life (4-10 minutes); therefore the potential advantage of an oxytocin infusion at caesarean section is in maintaining uterine contractility throughout the surgical procedure and immediate postpartum period, when most primary haemorrhage occurs

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Primigravida or multigravida
  • Term (37 - 42 weeks),
  • Singleton pregnancies
  • Booked for elective caesarean section.
  • Accepting to participate in the study.

排除标准

  • • Medical disorders involving the heart, liver, kidney or brain.
  • Diabetes mellitus and hypertension.
  • Blood disorders (e.g. coagulopathies, thrombocytopenia)
  • Patients requiring blood transfusion due to anemia.
  • Risk factors for uterine atony e.g. macrosomia, polyhydramnios and multiple pregnancy.
  • Previous 2 or more cesarean section
  • Placenta previa or placental abruption
  • Previous major obstetric haemorrhage (>1000 ml) in previous deliveries.
  • Known fibroid or adenomyosis.
  • Women who received anticoagulant therapy.
  • Severe preeclampsis.
  • Uterine anomalies.

研究组 & 干预措施

study group

Experimental

100 women were assigned to receive an intravenous infusion of oxytocin 30 units in a rate 125 mL/hour minutes diluted into 500 mL of normal 0.9% sodium chloride) immediately after opening the visceral peritoneum just before incising the uterine wall during Cesarean section

干预措施: Oxytocin (Drug)

Control group

Active Comparator

100 women were assigned to an intravenous infusion of oxytocin 30 units in a rate 125 mL/hour diluted into 500 mL of normal 0.9% sodium chloride) immediately after clamping the umbilical cord during cesarean section

干预措施: Oxytocin (Drug)

结局指标

主要结局

rate of blood loss

时间窗: 4 hours

collection of the blood in the drape below the patient

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验